Stocks and Investing Stocks and Investing
Tue, September 3, 2024

Brian Abrahams Reiterated (XENE) at Buy and Held Target at $55 on, Sep 3rd, 2024


Published on 2024-10-28 14:01:05 - WOPRAI, Brian Abrahams
  Print publication without navigation


Brian Abrahams of RBC Capital, Reiterated "Xenon Pharmaceuticals Inc." (XENE) at Buy and Held Target at $55 on, Sep 3rd, 2024.

Brian has made no other calls on XENE in the last 4 months.



There are 4 other peers that have a rating on XENE. Out of the 4 peers that are also analyzing XENE, 0 agree with Brian's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Brian


  • Serge Belanger of "Needham" Maintained at Strong Buy with Decreased Target to $60 on, Monday, August 12th, 2024
  • Josh Schimmer of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $65 on, Friday, August 9th, 2024
  • Laura Chico of "Wedbush" Maintained at Buy with Decreased Target to $49 on, Friday, August 9th, 2024
  • David Hoang of "Citigroup" Maintained at Strong Buy with Decreased Target to $60 on, Friday, May 10th, 2024
Contributing Sources